UwU Lend security incident triggers Curve founder CRV's loan position liquidation
The representative of Curve founder Michael Egorov stated via a Telegram message on Friday that a vulnerability in UwULend triggered a series of events on Monday, leading to massive liquidations at Curve on Thursday. The $100 million loan that Egorov obtained from various protocols using Curve's CRV token as collateral began automatic liquidation on Thursday, causing the token to drop by 30%, and then briefly recovered. Egorov said: "On April 15th, they (UwULend) deployed vulnerable code for the new (sUSDe) market. These markets are not isolated, so the entire platform was at risk. UwU was hacked and as part of cashing out activities, hackers deposited stolen CRV from UwU into lending.curve.fi (LlamaLend), then disappeared with the funds leaving debt in the system."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver
Driven by booming semiconductor exports, South Korea's current account surplus in September surged to a record high.

CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading
CoreWeave (CRWV.US) bonds fell sharply on Wednesday, with some dropping to new lows.

AstraZeneca (AZN.US) reportedly receives a $10 billion acquisition offer! Shares of obesity drug developer Rhythm (RYTM.US) soar in response
According to three people familiar with the matter, AstraZeneca previously proposed to acquire obesity drug developer Rhythm Pharmaceuticals for approximately 10 billion dollars.
Goldman Sachs and Apollo in Talks to Sell 40 Billion-Dollar AI Chip Financing for SpaceX (SPCX.US), Market's Willingness to Take Over Faces Test
Goldman Sachs (GS.US) and Apollo Global Management (APO.US) are in talks with Wall Street investors to begin selling portions of a roughly $40 billion chip financing deal for SpaceX (SPCX.US).
